”Our priority, as always, is to ensure that any transaction delivers the maximum value for shareholders”
Rikki
Have you ever researched small cap biotechs etc
Imo
Like the last 3-5 years
Imo
One should wait for CR before misleading statements like above
imo
Retail holders rarely come out trumps when biotechs need to advance
dyor
Ann: Kazia Annual Report, page-6
-
- There are more pages in this discussion • 141 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)